ArticleBMC cancer2023

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.